Synapticure Inc.

Funding and NIH signals

• NIH award NIH awarded $1.25M (SBIR Phase II 5R44NS143521-02, continuation, notice May 26, 2026). NIH RePORTER 5R44NS143521-02 (May 26, 2026)
  Evidence (1 event)

  • May 26, 2026 · NIH RePORTER 5R44NS143521-02
    Organization: SYNAPTICURE, INC.; City/State: KENILWORTH, IL; Project number: 5R44NS143521-02; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-05-26; FY total cost (award amount): 1246192; Administering IC: National Institute of Neurological Disorders and Stroke; Project title: 3D in vitro model of genetic and sporadic FTD: accelerating novel therapeutic development; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals

Raises and deals from press releases

• Raise Series A · $25M · announced Nov 19, 2024 Company release ↗
  Source quote

  • Nov 19, 2024 · Company release ↗
    “- Synapticure , a leading virtual care company dedicated to improving access and outcomes for patients and caregivers living with Alzheimer’s and related dementias, Parkinson’s, and other neurodegenerative diseases, today announced the successful close of its $25 million Series A funding round”

Raises announced in these releases: $25M disclosed.

From the company’s own releases; this list is partial. All raises and deals